StockNews.com downgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a strong-buy rating to a buy rating in a report published on Monday. VRTX has been the subject of several other research reports. Royal Bank of Canada upped their price objective on shares of Vertex Pharmaceuticals from $417.00 to $424.00 and gave the stock […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report issued on Sunday. Other analysts have also issued reports about the stock. Canaccord Genuity Group reissued a “sell” rating and set a $371.00 target price on shares of Vertex […]
Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to "Buy" at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Vertex Pharmaceuticals (NASDAQ:VRTX) Given Buy Rating at HC Wainwright wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $466.00 by Analysts at UBS Group themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Given Average Rating of "Hold" by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com cut shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Saturday morning. A number of other equities analysts have also recently weighed in on the stock. Truist Financial upped their price objective on shares of Vertex Pharmaceuticals from $456.00 […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “overweight” rating reissued by research analysts at Cantor Fitzgerald in a research report issued on Tuesday, Benzinga reports. They presently have a $440.00 price objective on the pharmaceutical company’s stock. Cantor Fitzgerald’s price objective suggests a potential upside of 5.44% from the company’s current price. […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective hoisted by equities research analysts at JPMorgan Chase & Co. from $390.00 to $438.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the pharmaceutical company’s stock. JPMorgan Chase & Co.‘s price […]
Canaccord Genuity Group cut shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a hold rating to a sell rating in a research report sent to investors on Wednesday morning, MarketBeat.com reports. The brokerage currently has $379.00 target price on the pharmaceutical company’s stock, up from their prior target price of $332.00. VRTX has been […]